Literature DB >> 28116594

Overlap of Dyspepsia in Patients with Gastroesophageal Reflux Disease: Impact of Clinical, Metabolic, and Psychosocial Characteristics.

Ching-Sheng Hsu1,2,3, Shu-Hui Wen4, Jui-Sheng Hung3,5, Tso-Tsai Liu3,5, Chih-Hsun Yi3,5, Wei-Yi Lei3,5, Fabio Pace6, Chien-Lin Chen7,8.   

Abstract

BACKGROUND: Gastroesophageal reflux disease (GERD) and dyspepsia are highly prevalent in the general population with significant symptom overlap, while the interaction between both remains poorly understood. AIM: To examine whether GERD overlapping dyspepsia would have an impact on clinical and psychological features as compared with GERD alone.
METHODS: We performed a cross-sectional study in a GERD cohort (n = 868) that was previously recruited from a population-based GERD survey (n = 2752). We compared the clinical and psychological factors between patients with and without dyspeptic symptoms "epigastric pain or burning." All participants were evaluated with Reflux Disease Questionnaire score, Pittsburgh Sleep Quality Index score, Taiwanese Depression Questionnaire score, and State-Trait Anxiety Inventory score. Endoscopic findings were classified according to the Los Angeles classification.
RESULTS: Among the GERD population, 107 subjects had overlapping "epigastric pain or burning" (GERD-D), and 761 did not have these symptoms (GERD alone). GERD-D subjects had more severe GERD symptoms and were more often associated with irritable bowel syndrome (IBS) (OR 3.54, 95% CI 1.92-6.52) as compared subjects with GERD alone. In addition, GERD-D subjects had lower quality of sleep (OR 1.11, 95% CI 1.01-1.21), higher depression (OR 1.06, 95% CI 1.02-1.10), lower blood pressure (OR 0.45, 95% CI 0.22-0.95), and higher serum total cholesterol levels (OR 2.78, 95% CI 1.36-5.67) than GERD alone.
CONCLUSIONS: GERD-D subjects are characterized with worsening clinical symptoms as well as higher psychosocial, IBS, and metabolic comorbidities, but less erosive esophagitis. Our results indicate that clinical awareness of such overlapping condition would help optimize the management of GERD in clinical practice.

Entities:  

Keywords:  Cross-sectional study; Dyspepsia; Humans; Questionnaires

Mesh:

Year:  2017        PMID: 28116594     DOI: 10.1007/s10620-017-4455-8

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  40 in total

1.  Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection.

Authors:  Ching-Sheng Hsu; Wei-Liang Liu; You-Chen Chao; Hans Hsienhong Lin; Tai-Chung Tseng; Chia-Chi Wang; Ding-Shinn Chen; Jia-Horng Kao
Journal:  Hepatol Int       Date:  2015-03-12       Impact factor: 6.047

2.  The burden of selected digestive diseases in the United States.

Authors:  Robert S Sandler; James E Everhart; Mark Donowitz; Elizabeth Adams; Kelly Cronin; Clifford Goodman; Eric Gemmen; Shefali Shah; Aida Avdic; Robert Rubin
Journal:  Gastroenterology       Date:  2002-05       Impact factor: 22.682

3.  Anxiety and depression in various functional gastrointestinal disorders: do differences exist?

Authors:  Juanda Leo Hartono; Sanjiv Mahadeva; Khean-Lee Goh
Journal:  J Dig Dis       Date:  2012-05       Impact factor: 2.325

4.  Increasing insulin resistance is associated with increased severity and prevalence of gastro-oesophageal reflux disease.

Authors:  C-S Hsu; P-C Wang; J-H Chen; W-C Su; T-C Tseng; H-D Chen; T-H Hsiao; C-C Wang; H H Lin; R-Y Shyu; Y-C Chao
Journal:  Aliment Pharmacol Ther       Date:  2011-08-17       Impact factor: 8.171

5.  Comparative analysis between psychological and endoscopic profiles in patients with gastroesophageal reflux disease: a prospective study based on screening endoscopy.

Authors:  Yi-Chia Lee; Hsiu-Po Wang; Han-Mo Chiu; Shih-Cheng Liao; Shih-Pei Huang; Yo-Ping Lai; Ming-Shiang Wu; Ming-Fong Chen; Jaw-Town Lin
Journal:  J Gastroenterol Hepatol       Date:  2006-05       Impact factor: 4.029

6.  Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior.

Authors:  Alexander C Ford; David Forman; Alastair G Bailey; Anthony T R Axon; Paul Moayyedi
Journal:  Am J Gastroenterol       Date:  2008-03-26       Impact factor: 10.864

Review 7.  Measures of anxiety: State-Trait Anxiety Inventory (STAI), Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A).

Authors:  Laura J Julian
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

8.  Predictive factors of silent reflux in subjects with erosive esophagitis.

Authors:  Wei-Yi Lei; Hao-Chun Yu; Shu-Hui Wen; Tso-Tsai Liu; Chih-Hsun Yi; Chia-Chi Wang; Ching-Sheng Hsu; Chien-Hwa Chen; Chien-Lin Chen; Fabio Pace
Journal:  Dig Liver Dis       Date:  2014-10-11       Impact factor: 4.088

9.  Epidemiology of uninvestigated and functional dyspepsia in Asia: facts and fiction.

Authors:  Uday C Ghoshal; Rajan Singh; Full-Young Chang; Xiaohua Hou; Benjamin Chun Yu Wong; Udom Kachintorn
Journal:  J Neurogastroenterol Motil       Date:  2011-07-13       Impact factor: 4.924

10.  Functional Dyspepsia in Review: Pathophysiology and Challenges in the Diagnosis and Management due to Coexisting Gastroesophageal Reflux Disease and Irritable Bowel Syndrome.

Authors:  Shadi S Yarandi; Jennifer Christie
Journal:  Gastroenterol Res Pract       Date:  2013-05-16       Impact factor: 2.260

View more
  6 in total

Review 1.  Review of antireflux procedures for proton pump inhibitor nonresponsive gastroesophageal reflux disease.

Authors:  L Hillman; R Yadlapati; M Whitsett; A J Thuluvath; M A Berendsen; J E Pandolfino
Journal:  Dis Esophagus       Date:  2017-09-01       Impact factor: 3.429

2.  Heartburn in children and adolescents in the presence of functional dyspepsia and/or irritable bowel syndrome correlates with the presence of sleep disturbances, anxiety, and depression.

Authors:  Jennifer M Colombo; Amanda D Deacy; Jennifer V Schurman; Craig A Friesen
Journal:  Medicine (Baltimore)       Date:  2021-04-02       Impact factor: 1.817

3.  Gastroesophageal reflux GWAS identifies risk loci that also associate with subsequent severe esophageal diseases.

Authors:  Jiyuan An; Puya Gharahkhani; Matthew H Law; Jue-Sheng Ong; Xikun Han; Catherine M Olsen; Rachel E Neale; John Lai; Tom L Vaughan; Ines Gockel; René Thieme; Anne C Böhmer; Janusz Jankowski; Rebecca C Fitzgerald; Johannes Schumacher; Claire Palles; David C Whiteman; Stuart MacGregor
Journal:  Nat Commun       Date:  2019-09-16       Impact factor: 14.919

4.  Gastroesophageal reflux disease in a typical African population: a symptom-based multicenter study.

Authors:  Sylvester Chuks Nwokediuko; Olusegun Adekanle; Adegboyega Akere; Abdulfatai Olokoba; Chiedozie Anyanechi; Sabo Mustapha Umar; Abubakar Maiyaki; Uchenna Ijoma; Olive Obienu; Augustine Uhunmwangho; Dennis Ndububa
Journal:  BMC Gastroenterol       Date:  2020-04-15       Impact factor: 3.067

5.  Salivary Pepsin as an Intrinsic Marker for Diagnosis of Sub-types of Gastroesophageal Reflux Disease and Gastroesophageal Reflux Disease-related Disorders.

Authors:  Yan-Jun Wang; Xiu-Qiong Lang; Dan Wu; Yu-Qin He; Chun-Hui Lan; Xiao Xiao; Bin Wang; Duo-Wu Zou; Ji-Min Wu; Yong-Bin Zhao; Peter W Dettmar; Dong-Feng Chen; Min Yang
Journal:  J Neurogastroenterol Motil       Date:  2020-01-30       Impact factor: 4.924

6.  Correlation between the symptoms of upper gastrointestinal disease and endoscopy findings: Implications for clinical practice.

Authors:  Maria Aparecida A O Serra; Arlene T Medeiros; Mateus D Torres; Ismália Cassandra C M Dias; Carlos Alberto A S Santos; Márcio Flávio M Araújo
Journal:  J Taibah Univ Med Sci       Date:  2021-02-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.